THERAVANCE INC
Net SellingTHRX·US·🇺🇸 US
34%buys·66%sales
1,426 transactions$376602.1BTotal buys·178 buys
$518.0MTotal sells·347 sells
8181 insiders
Last: Nov 20, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Nov 20, 25 | Zhen Marianne | Other | $21K | |
| Nov 20, 25 | Basso Stephen | Other | $5K | |
| Nov 15, 25 | Basso Stephen | Grant | - | |
| Nov 3, 25 | Raifeld Pavel | Grant | $2.0M | |
| Nov 3, 25 | Basso Stephen | Grant | $500K | |
| Aug 20, 25 | Zhen Marianne | Other | $20K | |
| Aug 20, 25 | Basso Stephen | Other | $5K | |
| May 20, 25 | Basso Stephen | Other | $4K | |
| May 20, 25 | Zhen Marianne | Other | $19K | |
| May 19, 25 | Haimovitz Jules | Grant | - |
THERAVANCE INC (THRX) has recorded 1 426 insider transactions from 81 insiders. Total insider buying volume stands at $376602.1B, while total selling volume is $518.0M. Overall insider sentiment is bearish (66% sales).
THERAVANCE INC (THRX) has recorded 1 426 insider operations, including 178 open-market purchases ($376602.1B), 347 sales ($518.0M) and 901 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (66% sales).
THERAVANCE INC shows moderate insider activity with 6 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are CLACKSON TIMOTHY P (CEO), Winningham Rick E (CEO) & Aguiar Michael W (CEO), with respectively 222, 213, 72 transactions.
Across all 1 426 recorded transactions, the breakdown by type is: grant (451, 32%), sales (347, 24%), exercise (202, 14%), tax (194, 14%), buys (178, 12%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
THERAVANCE INC has recorded 1 426 insider operations in total, including 178 open-market purchases ($376602.1B), 347 sales ($518.0M) and 901 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on November 20, 2025.
Insiders at THERAVANCE INC are currently net sellers, with 34% purchases and 66% sales across all reported transactions. Total buy volume is $376602.1B versus $518.0M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 81 insiders at THERAVANCE INC (THRX). CLACKSON TIMOTHY P (CEO, 222 tx), Winningham Rick E (CEO, 213 tx), Aguiar Michael W (CEO, 72 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for THRX is bearish, based on a 34% buy ratio across 525 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for THERAVANCE INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.